Sedimentum closes its next financing round of CHF 3.3 Mio.

Only six months after closing its seed round of CHF 2.1 million, the successful healthtech start-up closes its pre-series A financing round of CHF 3.3 million. With this new capital, Sedimentum intends to conquer the Swiss B2C market with its intelligent SAFE-living solution.

Why do you need a European Authorised Representative?

The new Regulations for medical devices and in vitro diagnostic devices create a more robust, transparent, and sustainable regulatory framework. In this article, we will tell you all you need to know to be up to date to the new requirements implemented by the European Commission.

How to optimize patient safety and care coordination in clinical trials?

Increasing patients’ safety and care in research is vital when preparing and conducting your study. From a HEMEX perspective, we are tackling in this article four important points you should consider during the process.

Progress too slow for equality in science

February 11 is commemorated worldwide as the International Day of Women and Girls in Science by the United Nations General Assembly. Unfortunately, there is still a significant gender gap at all levels of science, technology, engineering, and mathematics (STEM) disciplines all over the world. At HEMEX, we ask ourselves, how is this still happening in the middle of the Fourth Industrial Revolution?